Precipio (PRPO) Shares Down 8.4%
Shares of Precipio Inc (NASDAQ:PRPO) fell 8.4% during trading on Wednesday . The company traded as low as $0.21 and last traded at $0.22. 1,140,819 shares traded hands during mid-day trading, an increase of 87% from the average session volume of 610,784 shares. The stock had previously closed at $0.24.
The company has a quick ratio of 0.13, a current ratio of 0.14 and a debt-to-equity ratio of 0.30.
Precipio (NASDAQ:PRPO) last posted its earnings results on Monday, November 19th. The biotechnology company reported ($0.13) EPS for the quarter. The business had revenue of $0.65 million during the quarter. Precipio had a negative return on equity of 149.24% and a negative net margin of 610.39%.
Precipio Company Profile (NASDAQ:PRPO)
Precipio, Inc, a cancer diagnostics company, provides diagnostic products and services to the oncology market. It also develops a platform to eradicate the problem of misdiagnosis within academic institutions. In addition, the company delivers diagnostic information to physicians and their patients. It has collaborations with academic institutions specializing in cancer research, diagnostics, and treatment, as well as PerkinElmer.
Featured Article: Understanding the different types of bonds
Receive News & Ratings for Precipio Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Precipio and related companies with MarketBeat.com's FREE daily email newsletter.